CuraTeQ Biologics Private Limited – Trademark Portfolio
Entity Type: 99
CuraTeQ Biologics Private Limited holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 5 trademarks are registered and 3 are pending. Notable registered marks include DYRUPEG, ZEFYLTI, BEVQOLVA, DAZUBLYS, and OMAZIJEV.
Galaxy, Floors 22-24, Plot No. 1,
Survey No. 83/1, Hyderabad Knowledge Raidurg, Panmaktha, Hyderabad, Telangana 500032
Showing of trademarks Trademarks
Trademark Classifications
CuraTeQ Biologics Private Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CuraTeQ Biologics Private Limited have?
CuraTeQ Biologics Private Limited has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 pending, 2 abandoned.
What trademark classes does CuraTeQ Biologics Private Limited file in?
CuraTeQ Biologics Private Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CuraTeQ Biologics Private Limited's most well-known trademarks?
CuraTeQ Biologics Private Limited's registered trademark portfolio includes well-known marks such as DYRUPEG, ZEFYLTI, BEVQOLVA, DAZUBLYS, and OMAZIJEV. These are among 5 currently registered trademarks in the portfolio.
What is CuraTeQ Biologics Private Limited's trademark registration success rate?
CuraTeQ Biologics Private Limited has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 3 applications are pending review.